AXIM Biotechnologies, Inc. announced that it has entered into a securities purchase agreement with Catalina Valencia for a private placement of 3,861,004 restricted shares at a price of $0.0259 per share for gross proceeds of $100,000.0036 on August 24, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0114 USD | -6.15% | -16.06% | -39.47% |
1st Jan change | Capi. | |
---|---|---|
-39.47% | 3.19M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- AXIM Stock
- News AXIM Biotechnologies, Inc.
- AXIM Biotechnologies, Inc. announced that it expects to receive $0.1 million in funding